EUVIMEDEUVIMED entdecken
Crossref

JMJD2A mediates transcriptional activation of SFRP4 and regulates oxidative stress and mitochondrial dysfunction in heart failure

Mingming Ren, Xiaoqiang Ye, Chun Ouyang, Qing'en Da, Weiwei Xue, Piji Chen

Pathology International · 2024

DOI: 10.1111/pin.13413 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology International, 2024. Verfasst von Mingming Ren und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Heart Failure, Mitochondrial Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The importance of mitochondrial dysfunction and oxidative stress has been indicated in the progression of heart failure (HF). The molecular mechanisms, however, remain to be fully elucidated. This study aimed to explore the role and underlying mechanism of secreted frizzled‐related protein 4 (SFRP4) in these two events in HF. Mice with HF were developed using transverse aortic constriction, and hematoxylin‐eosin staining, MASSON staining, and Terminal deoxynucleotidyl transferase (TdT)‐mediated 2'‐Deoxyuridine 5'‐ Triphosphate nick end labeling (TUNEL assays) were conducted to detect morphological damage in the myocardial tissues of mice. HL‐1 mouse cardiomyocytes were induced with isoproterenol (ISO), and cell viability and apoptosis were examined using cell counting kit‐8 and TUNEL assays. SFRP4 and Jumonji domain‐containing protein 2A (JMJD2A) were highly expressed in myocardial tissues. Suppression of SFRP4 alleviated apoptosis and fibrosis in myocardial tissues of mice. In addition, the extent of mitochondrial dysfunction and oxidative stress in damaged myocardial tissues and HL‐1 cells was mitigated by SFRP4 inhibition as well. JMJD2A catalyzed demethylation modification of the SFRP4 promoter, thus promoting SFRP4 transcription in the development of HF. JMJD2A is responsible for SFRP4 transcription activation in the failing hearts of mice. Blockade of JMJD2A or SFRP4 might be a novel therapy effective in mitigating HF progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureMitochondrial DiseasesAnimalsMiceApoptosisOxidative StressPromoter Regions, GeneticTranscriptional ActivationHistone DemethylasesSecreted Frizzled-Related Proteins

Stichwörter der Autor:innen

JMJD2ASFRP4heart failuremitochondrial dysfunctionoxidative stress

Substanzen

JMJD2A protein, mouseHistone DemethylasesSfrp4 protein, mouseSecreted Frizzled-Related Proteins

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.
  • Department of Clinical Laboratory, Yantian People's Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, China.

Zitieren

APA

Ren, M., Ye, X., Ouyang, C., Da, Q., Xue, W., & Chen, P. (2024). JMJD2A mediates transcriptional activation of SFRP4 and regulates oxidative stress and mitochondrial dysfunction in heart failure. Pathology International. https://doi.org/10.1111/pin.13413

Vancouver

Ren M, Ye X, Ouyang C, Da Q, Xue W, Chen P. JMJD2A mediates transcriptional activation of SFRP4 and regulates oxidative stress and mitochondrial dysfunction in heart failure. Pathology International. 2024. doi:10.1111/pin.13413

BibTeX
@article{Ren2024,
  author = {Ren, Mingming and Ye, Xiaoqiang and Ouyang, Chun and Da, Qing'en and Xue, Weiwei and Chen, Piji},
  title = {JMJD2A mediates transcriptional activation of SFRP4 and regulates oxidative stress and mitochondrial dysfunction in heart failure},
  journal = {Pathology International},
  year = {2024},
  doi = {10.1111/pin.13413}
}
Kostenlos starten →